Chicago, IL (February 26, 2016) – Epstein Becker Green is pleased to announce that Law360 has selected Amy K. Dow to serve for a second consecutive year on the publication’s Life Sciences editorial advisory board for 2016.
According to Law360, “the purpose of the editorial advisory board is to get feedback on Law360's coverage and to gain insight from experts in the field on how best to shape future coverage.”
Ms. Dow is a member in Epstein Becker Green's health care and life sciences practice in the firm's Chicago office. She primarily represents pharmaceutical, medical device and biologics manufacturers in U.S. Food and Drug Administration regulatory, fraud and abuse and transactional matters. Ms. Dow also provides health regulatory due diligence services to private equity firms and other investors in life sciences sector entities.
About Epstein Becker Green
Epstein Becker Green is a national law firm focused on health care and life sciences; employment, labor, and workforce management; and litigation and business disputes. Our attorneys advise clients at every stage of their business lifecycle, delivering practical, results-driven counsel that shapes strategy, accelerates growth, and safeguards what matters most. We serve organizations of every size, from emerging startups to Fortune 100 companies, across the health care, life sciences, financial services, retail, hospitality, and technology industries, with sound legal solutions they can depend on when it counts. www.ebglaw.com
People
- Board of Directors / Member of the Firm
Services
Industries
Media Contact
- Director of Marketing Communications